Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds.
The prophylactic activity of intranasal human interferon-alpha 2 (HuIFN-alpha 2) against natural rhinovirus colds was determined in a randomized, double-blind, placebo-controlled trial. A total of 304 working adults self-administered sprays of HuIFN-alpha 2 (10(7) IU/day) or a placebo once daily. Du...
Gardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1984
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC179911/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6089652/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.1.31 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|